Microbiologic outcomes of ceftazidime-avibactam dosing in patients with sepsis utilizing renal replacement therapies.

Saved in:
Bibliographic Details
Title: Microbiologic outcomes of ceftazidime-avibactam dosing in patients with sepsis utilizing renal replacement therapies.
Authors: El Nekidy WS; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Al Ali M; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Abidi E; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Ghazi IM; Arnold and Marie Schwartz College of Pharmacy, Long Island University, Brookville, New York, USA., Attallah N; Department of Nephrology, Nephrology Associates of Kentuckiana, Louisville, Kentucky, USA., El Lababidi R; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Mooty M; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Ghosn M; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Mallat J; Department of Pharmacy, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.; Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Source: Hemodialysis international. International Symposium on Home Hemodialysis [Hemodial Int] 2023 Jul; Vol. 27 (3), pp. 289-295. Date of Electronic Publication: 2023 May 05.
Publication Type: Observational Study; Journal Article
Journal Info: Publisher: Blackwell Pub Country of Publication: Canada NLM ID: 101093910 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-4758 (Electronic) Linking ISSN: 14927535 NLM ISO Abbreviation: Hemodial Int Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1542-4758
DOI:10.1111/hdi.13090